Abstract: Disclosed are a brightness control apparatus and method, and a display apparatus. The brightness control apparatus includes an optical detection circuit and an integrated circuit chip connected with the optical detection circuit. The optical detection circuit includes at least one transistor, configured to detect a light intensity of light to be detected corresponding to an environment where a display panel is located, and generate an electrical signal corresponding to the light intensity of the light to be detected.

Abstract: Disclosed herein are factor H variants, vectors comprising said factor H variants, and pharmaceutical compositions comprising the same for treatment of disorders.

Abstract: Provided herein are compositions and methods for preventing or reducing CARPA in a subject in need thereof. In one aspect, the composition comprises a therapeutic molecule, diagnostic molecule, molecular complex, or nanoparticle having a complement inhibitory protein attached thereto.

Abstract: Disclosed herein are factor H variants, vectors comprising said factor H variants, and pharmaceutical compositions comprising the same for treatment of disorders.

Abstract: This invention relates to inhibition of the complement signaling using a humanized anti-C5a antibody. Specifically, the invention relates to methods of treating a complement-mediated disease or complement-mediated disorder in an individual by contacting the individual with the humanized anti-C5a antibody.

Abstract: This invention relates to inhibition of the complement signaling using an anti-C5 antibody. Specifically, the invention relates to methods of treating a complement-mediated disease or complement-mediated disorder in an individual by contacting the individual with an anti-C5 antibody.

Abstract: A spiral magnetic fluid composite sealing structure of a roller bit comprising a cone leg and a roller, wherein the roller and the cone leg are in rotatable connection in a fitting manner through a roller inner hole and a cone leg shaft journal, a sealing groove is formed in an opening end of the roller inner hole, and a spiral magnetic fluid sealing assembly is arranged in the sealing groove. Through the arrangement of the spiral magnetic fluid sealing assembly, a spiral sand discharging effect is realized, compared with a passive sealing mode, the sealing performance is greatly improved by active sand discharging mode, and the service life of sealing is significantly prolonged; a slurry sealing effect of magnetic fluid seals is realized, resulting the sealing gap is tightly sealed under the magnetic action; in addition, the automatic compensation function of magnetic fluid can also be realized.

Abstract: In method for catalytic synthesis of crude ethylene sulfate, a sulfur trioxide solution is prepared by dissolving sulfur trioxide with a solution A, an ethylene oxide solution is prepared by mixing a solution B with ethylene oxide, a catalyst is added to the sulfur trioxide solution and mixing them to obtain a mixed solution C, the ethylene oxide solution and the mixed solution C are pre-cooled, and then introduced into a set of microchannel reactors for a real-time reaction to obtain a mixed solution containing crude ethylene sulfate, and then a post-treatment process is carried out to obtain crude ethylene sulfate. With the process, the reaction selectivity is good, and a microchannel reaction can accurately control the reaction energy level due to its rapid mixing and timely heat transfer, which greatly reduces the safety risk and effectively avoids the occurrence of side reactions.

Abstract: In a method for preparing electronic-grade vinyl sulfate, a sulfur trioxide solution is prepared by dissolving sulfur trioxide with a solution A, an ethylene oxide solution is prepared by mixing a solution B with ethylene oxide, the sulfur trioxide solution and the ethylene oxide solution are pre-cooled, and introduced into a set of microchannel reactors for a real-time reaction to obtain a mixed solution containing crude vinyl sulfate, and then a post-treatment process is carried out to obtain crude vinyl sulfate. With the process, the reaction selectivity is good, and a microchannel reaction can accurately control the reaction energy level due to its rapid mixing and timely heat transfer, which greatly reduces the safety risk and effectively avoids the occurrence of side reactions. One-step synthesis is realized, the atomic economic benefits are significantly improved, and thus the process is a typical low-carbon green chemical reaction.

Abstract: In a method for continuously preparing crude ethylene sulfate, a sulfur trioxide solution is prepared by dissolving sulfur trioxide with a solution A, an ethylene oxide solution is prepared by mixing a solution B with ethylene oxide, the sulfur trioxide solution and the ethylene oxide solution are pre-cooled, and introduced into a set of microchannel reactors for a real-time reaction to obtain a mixed solution containing crude ethylene sulfate, and then a post-treatment process is carried out to obtain crude ethylene sulfate. With the process, the reaction selectivity is good, and a microchannel reaction can accurately control the reaction energy level due to its rapid mixing and timely heat transfer, which greatly reduces the safety risk and effectively avoids the occurrence of side reactions. One-step synthesis is realized, the atomic economic benefits are significantly improved, and thus the process is a typical low-carbon green chemical reaction.

Abstract: This invention relates to inhibition of the complement signaling using an anti-C5 antibody or fusion protein thereof. Specifically, the invention relates to methods of treating a complement-mediated disease or complement-mediated disorder in an individual by contacting the individual with an anti-C5 antibody fusion protein thereof.

Abstract: A spiral magnetic fluid composite sealing structure of a roller bit comprising a cone leg and a roller, wherein the roller and the cone leg are in rotatable connection in a fitting manner through a roller inner hole and a cone leg shaft journal, a sealing groove is formed in an opening end of the roller inner hole, and a spiral magnetic fluid sealing assembly is arranged in the sealing groove. Through the arrangement of the spiral magnetic fluid sealing assembly, a spiral sand discharging effect is realized, compared with a passive sealing mode, the sealing performance is greatly improved by active sand discharging mode, and the service life of sealing is significantly prolonged; a slurry sealing effect of magnetic fluid seals is realized, resulting the sealing gap is tightly sealed under the magnetic action; in addition, the automatic compensation function of magnetic fluid can also be realized.

Abstract: This invention relates to inhibition of the complement signaling using an anti-C5 antibody. Specifically, the invention relates to methods of treating a complement-mediated disease or complement-mediated disorder in an individual by contacting the individual with an anti-C5 antibody.

Abstract: This invention relates to factor B inhibitors or nucleic acid molecules encoding thereof and selective inhibition of the alternative pathway (AP) of the complement system using said factor B inhibitors or nucleic acid molecules encoding thereof or compositions thereof. The invention also provides methods of treating an AP complement-mediated disease or AP complement-mediated disorder in a subject by administering a therapeutically effective amount of the factor B inhibitor or nucleic acid molecules encoding thereof or composition thereof.

Abstract: This invention relates to inhibition of the complement signaling using an anti-C5 antibody. Specifically, the invention relates to methods of treating a complement-mediated disease or complement-mediated disorder in an individual by contacting the individual with an anti-C5 antibody.

Abstract: This invention relates to selective inhibition of the alternative pathway (AP) of the complement system using an anti-factor D antibody. Specifically, the invention relates to methods of treating an AP-mediated disease or AP-mediated disorder in an individual by contacting the individual with an anti-factor D antibody.

Abstract: This invention relates to selective inhibition of the alternative pathway (AP) of the complement system using an anti-factor D antibody. Specifically, the invention relates to methods of treating an AP-mediated disease or AP-mediated disorder in an individual by contacting the individual with an anti-factor D antibody.

Abstract: This invention relates to inhibition of the complement signaling using an anti-C5 antibody or fusion protein thereof. Specifically, the invention relates to methods of treating a complement-mediated disease or complement-mediated disorder in an individual by contacting the individual with an anti-C5 antibody fusion protein thereof.

Abstract: This invention relates to inhibition of the complement signaling using an anti-C5 antibody. Specifically, the invention relates to methods of treating a complement-mediated disease or complement-mediated disorder in an individual by contacting the individual with an anti-C5 antibody.

Abstract: This invention relates to inhibition of the complement signaling using an anti-C5a antibody. Specifically, the invention relates to methods of treating a complement-mediated disease or complement-mediated disorder in an individual by contacting the individual with an anti-C5a antibody.